Ghent University Academic Bibliography

Journal Article
A1
open access

Chitosan/γ-PGA nanoparticles and IFN-γ immunotherapy : a dual approach for triple-negative breast cancer treatment

Flávia Raquel Teixeira De Castro, Marta Laranjeiro Pinto, Catarina Leite Pereira, Karine Serre, Ângela Margarida Costa, Bruno Cavadas, Mário Adolfo Barbosa, Karim Vermaelen (UGent) , Sergio León, Diego Serrano, et al.

(2025) JOURNAL OF CONTROLLED RELEASE. 379. p.621-635

Add to list

Journal Article
A1
open access

Engineered dendritic cells-derived extracellular vesicles for cancer immunotherapy

Margarida Oliveira Coelho, Sofia Torres Quintas, Bruno Sarmento, Olivier De Wever (UGent) and Flávia Raquel Teixeira De Castro

(2025) JOURNAL OF CONTROLLED RELEASE. 381.

Add to list

Allogeneic stem cells engineered to release interferon β and scFv-PD1 target glioblastoma and alter the tumor microenvironment

Ioulia Vogiatzi (UGent) , Lucia Moreno Lama, Amelia Lehmann, Filippo Rossignoli, Jan Gettemans (UGent) and Khalid Shah

(2024) CYTOTHERAPY. 26(10). p.1217-1226

Add to list

Journal Article
A1
open access

Saccharomyces cerevisiae derived postbiotic alters gut microbiome metabolism in the human distal colon resulting in immunomodulatory potential n vitro

Cindy Duysburgh, Lisa Miclotte, Justin B. Green, Kevin T. Watts, Maria I. Sardi, Anirikh Chakrabarti, Ehsan Khafipour and Massimo Marzorati (UGent)

(2024) FRONTIERS IN MICROBIOLOGY. 15.

Add to list

Journal Article
A1
open access

Mechanistic pathways and clinical implications of GLP-1 receptor agonists in type 1 diabetes management

Charlotte Delrue (UGent) and Marijn Speeckaert (UGent)

(2024) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 25(17).

Add to list

Journal Article
A1
open access

Ex vivo colonic fermentation of NUTRIOSE® exerts immuno-modulatory properties and strong anti-inflammatory effects

Caroline Perreau, Clementine Thabuis, Lynn Verstrepen, Jonas Ghyselinck and Massimo Marzorati (UGent)

(2023) NUTRIENTS. 15(19).

Add to list

Journal Article
A1
open access

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, An M. T. Van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Lien Lippens (UGent) , Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, et al.

(2023) CANCER IMMUNOLOGY IMMUNOTHERAPY. 72(2). p.475-491

Add to list

Journal Article
A1
open access

Low-dose xenogeneic mesenchymal stem cells target canine osteoarthritis through systemic immunomodulation and homing

Charlotte Beerts, Sarah Broeckx, Eva Depuydt, Liesa Tack, Lore Van Hecke (UGent) , Koen Chiers (UGent) , Leen Van Brantegem (UGent) , Gabriele Braun, Klaus Hellmann, Nathalie de Bouvré, et al.

(2023) ARTHRITIS RESEARCH & THERAPY. 25(1).

Add to list

Journal Article
A1
open access

One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer

Jonas Steenbrugge (UGent) , Julie Bellemans (UGent) , Niels Vander Elst, Kristel Demeyere (UGent) , Josephine De Vliegher, Timothy Perera, Olivier De Wever (UGent) , Wim Van Den Broeck (UGent) , Ward De Spiegelaere (UGent) , Niek Sanders (UGent) , et al.

(2022) ONCOIMMUNOLOGY. 11(1).

Add to list

Splenic immunomodulatory effects of cisplatin in an immunocompetent intraductal model for triple-negative breast cancer

Jonas Steenbrugge (UGent) , Niels Vander Elst, Kristel Demeyere (UGent) , Josephine De Vliegher, Annegret Van der Aa, Eric Ciamporcero, Timothy Perera and Evelyne Meyer (UGent)

(2021) OncoDot.3 symposium, Abstracts.

Academic Bibliography

Chitosan/γ-PGA nanoparticles and IFN-γ immunotherapy : a dual approach for triple-negative breast cancer treatment

Engineered dendritic cells-derived extracellular vesicles for cancer immunotherapy

Allogeneic stem cells engineered to release interferon β and scFv-PD1 target glioblastoma and alter the tumor microenvironment

Saccharomyces cerevisiae derived postbiotic alters gut microbiome metabolism in the human distal colon resulting in immunomodulatory potential n vitro

Mechanistic pathways and clinical implications of GLP-1 receptor agonists in type 1 diabetes management

Ex vivo colonic fermentation of NUTRIOSE® exerts immuno-modulatory properties and strong anti-inflammatory effects

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

Low-dose xenogeneic mesenchymal stem cells target canine osteoarthritis through systemic immunomodulation and homing

One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer

Splenic immunomodulatory effects of cisplatin in an immunocompetent intraductal model for triple-negative breast cancer

Contents

Support

Contact